Inventor · disambiguated record
Roger John Gillespie
Also filed as: GILLESPIE ROGER J · GILLESPIE ROGER JOHN
35 granted patents·7 pending applications·843 citations·filing 1983–2022
98Inventor score
Top patents by PatentIndex Score
42 records- 0196US8987279B2Triazolo [4, 5-D] pyramidine derivatives and their use as purine receptor antagonistsVERNALIS R&D LTD·Filed 2013·Granted Mar 24, 2015·40 cites·16 claims
- 0294US9376443B2Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonistsVERNALIS R&D LTD·Filed 2015·Granted Jun 28, 2016·11 cites·20 claims
- 0394US7790713B2Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 2007·Granted Sep 7, 2010·24 cites·20 claims
- 0494US7405219B2Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2006·Granted Jul 29, 2008·44 cites·26 claims
- 0593US9765080B2Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonistsVERNALIS R&D LTD·Filed 2016·Granted Sep 19, 2017·9 cites·4 claims
- 0693US6423840B1Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 2001·Granted Jul 23, 2002·40 cites·10 claims
- 0792US6787541B1Thieno-and furopyrimidine derivatives as A2A-receptor antagonistsVERNALIS RES LTD·Filed 2000·Granted Sep 7, 2004·64 cites·40 claims
- 0892US6204261B1Inhibitors of interleukin-1β Converting enzyme inhibitorsVERTEX PHARMA·Filed 1996·Granted Mar 20, 2001·80 cites·34 claims
- 0992US5874424AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1996·Granted Feb 23, 1999·141 cites·7 claims
- 1091US8119631B2Inhibitors of interleukin-1β converting enzymeBATCHELOR MARK JAMES·Filed 2010·Granted Feb 21, 2012·24 cites·15 claims
- 1191US7141575B2Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2002·Granted Nov 28, 2006·45 cites·48 claims
- 1290US8450328B2Triazolo[4,5-D]pyramidine derivatives and their use as purine receptor antagonistsBAMFORD SAMANTHA JANE·Filed 2009·Granted May 28, 2013·16 cites·9 claims
- 1390US7589097B2Triazol[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2007·Granted Sep 15, 2009·18 cites·2 claims
- 1487US6828318B22-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmissionVERNALIS RES LTD·Filed 2001·Granted Dec 7, 2004·48 cites·34 claims
- 1585US6258948B1Inhibitors of Interleukin-1β converting enzymeVERTEX PHARMA·Filed 1999·Granted Jul 10, 2001·42 cites·46 claims
- 1682US10875868B2Triazolo[4,5-d] pyramidine derivatives and their use as purine receptor antagonistsVERNALIS R&D LTD·Filed 2019·Granted Dec 29, 2020·0 cites·3 claims
- 1782US6583156B14-Quinolinemethanol derivatives as purine receptor antagonists (1)VERNALIS RES LTD·Filed 1999·Granted Jun 24, 2003·33 cites·26 claims
- 1881US7629349B2Pyrazolo [3,4-d] pyrimidine derivatives and their use as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2006·Granted Dec 8, 2009·4 cites·47 claims
- 1980US6608085B14-quinolinemethanol derivatives as purine receptor antagonists (II)VERNALIS RES LTD·Filed 1999·Granted Aug 19, 2003·55 cites·33 claims
- 2077US11466019B2Triazolo[4,5-d] pyramidine derivatives and their use as purine receptor antagonistsVERNALIS R&D LTD·Filed 2020·Granted Oct 11, 2022·0 cites·4 claims
- 2177US7384949B2Thieno(3,2-d)pyrimidines and furano(3,2-d)pyrimidines and their use as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2002·Granted Jun 10, 2008·10 cites·30 claims
- 2276US7087754B2Pyrazolo[3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2002·Granted Aug 8, 2006·5 cites·39 claims
- 2376US2023100842A1Triazolo[4,5-d] pyramidine derivatives and their use as purine receptor antagonistsLIGAND UK DEVELOPMENT LTD·Filed 2022·Application pending·0 cites
- 2475US4925846A2-thiazolyl-imidazo[1,2,-a]pyrimidinesROUSSEL UCLAF·Filed 1987·Granted May 15, 1990·25 cites·10 claims
- 2574US7875600B2Pyrimidine compounds as purine receptor antagonistVERNALIS R&D LTD·Filed 2005·Granted Jan 25, 2011·2 cites·4 claims
- 2671US6008217AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1995·Granted Dec 28, 1999·37 cites·30 claims
- 2770US10538526B2Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonistsVERNALIS R&D LTD·Filed 2018·Granted Jan 21, 2020·0 cites·4 claims
- 2868US10106547B2Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonistsVERNALIS R&D LTD·Filed 2017·Granted Oct 23, 2018·0 cites·5 claims
- 2968US4547507ABenzothiopyranopyridinonesROUSSEL UCLAF·Filed 1983·Granted Oct 15, 1985·12 cites·27 claims
- 3066US7098333B2Pyrrolo[2,3-d]pyrimidine and their use as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2002·Granted Aug 29, 2006·2 cites·37 claims
- 3164US7452894B2Purine derivatives as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2002·Granted Nov 18, 2008·2 cites·31 claims
- 3261US6531511B12-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmissionVERNALIS RES LTD·Filed 2000·Granted Mar 11, 2003·2 cites·27 claims
- 3361US2005143436A1Inhibitors of interleukin-1beta converting enzymeVERTEX PHARMA·Filed 2004·Application pending·0 cites
- 3456US2008153820A1Thieno(3,2-d)pyrimidines and furano(3,2-d)pyramidines and their use as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2008·Application pending·0 cites
- 3554US7598256B2Pyrrolo [2,3-d] pyrimidine and their use as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2006·Granted Oct 6, 2009·0 cites·47 claims
- 3654US2003225269A1Inhibitors of interleukin-1beta converting enzymeVERTEX PHARMA·Filed 2002·Application pending·0 cites
- 3751US2006270691A1Purine derivatives as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2006·Application pending·0 cites
- 3847US2003130354A11-(Adamantyl) amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmissionVERNALIS RES LTD·Filed 2002·Application pending·0 cites
- 3942US4703049A2-(1,2,4-oxadiazol-5-yl) and 2-(1,3,4-thiadiazol-2-yl-imidazo[1,2-a]pyrimidinesROUSSEL UCLAF·Filed 1985·Granted Oct 27, 1987·3 cites·17 claims
- 4037US2012165319A1Inhibitors of interleukin-1 beta converting enzymeBATCHELOR MARK JAMES·Filed 2011·Application pending·0 cites
- 4136US6262106B1Adamantanecarboximidamide derivatives and their use as NMDA antagonistsVERNALIS RES LTD·Filed 1999·Granted Jul 17, 2001·3 cites·15 claims
- 4233US6500866B11-(adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmissionVERNALIS RES LTD·Filed 1998·Granted Dec 31, 2002·2 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →